These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10413072)

  • 21. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
    Morganroth J; Rüegg PC; Dunger-Baldauf C; Appel-Dingemanse S; Bliesath H; Lefkowitz M
    Am J Gastroenterol; 2002 Sep; 97(9):2321-7. PubMed ID: 12358251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cisapride on the QT interval in infants with gastroesophageal reflux.
    Khoshoo V; Edell D; Clarke R
    Pediatrics; 2000 Feb; 105(2):E24. PubMed ID: 10654984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proarrhythmia associated with cisapride in children.
    Hill SL; Evangelista JK; Pizzi AM; Mobassaleh M; Fulton DR; Berul CI
    Pediatrics; 1998 Jun; 101(6):1053-6. PubMed ID: 9606235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced ventricular tachyarrhythmia in isolated rabbit hearts with atrioventricular block.
    Kii Y; Ito T
    Pharmacol Toxicol; 2002 May; 90(5):246-53. PubMed ID: 12076305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
    Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
    J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?
    Carlsson L; Amos GJ; Andersson B; Drews L; Duker G; Wadstedt G
    J Pharmacol Exp Ther; 1997 Jul; 282(1):220-7. PubMed ID: 9223557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisapride associated with QTc prolongation in very low birth weight preterm infants.
    Dubin A; Kikkert M; Mirmiran M; Ariagno R
    Pediatrics; 2001 Jun; 107(6):1313-6. PubMed ID: 11389249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.
    Kii Y; Nakatsuji K; Nose I; Yabuuchi M; Mizuki Y; Ito T
    Pharmacol Toxicol; 2001 Aug; 89(2):96-103. PubMed ID: 11555327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.
    Nasr I; Rao SS; Attaluri A; Hashmi SM; Summers R
    Indian J Gastroenterol; 2009; 28(4):136-42. PubMed ID: 19937173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of magnesium on the electrophysiological effects of erythromycin in the isolated Guinea pig heart.
    Lueger A; Brodmann M; Scherr D; Stark G
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):327-33. PubMed ID: 12652102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
    J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of the QT interval related to cisapride-diltiazem interaction.
    Thomas AR; Chan LN; Bauman JL; Olopade CO
    Pharmacotherapy; 1998; 18(2):381-5. PubMed ID: 9545159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 5-HT(4) receptor agonist prokinetic agents on the action potential parameters of isolated rabbit myocardium.
    Noguchi K; Ito C; Isobe Y; Fukushima K; Tanaka Y; Tanaka H; Shigenobu K
    Pharmacology; 2001 Feb; 62(2):73-9. PubMed ID: 11174075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs.
    Katchman AN; Koerner J; Tosaka T; Woosley RL; Ebert SN
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1098-106. PubMed ID: 16278312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.
    van Haarst AD; van 't Klooster GA; van Gerven JM; Schoemaker RC; van Oene JC; Burggraaf J; Coene MC; Cohen AF
    Clin Pharmacol Ther; 1998 Nov; 64(5):542-6. PubMed ID: 9834046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
    Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954.
    Beattie DT; Higgins DL; Ero MP; Amagasu SM; Vickery RG; Kersey K; Hopkins A; Smith JA
    Vascul Pharmacol; 2013 Jan; 58(1-2):150-6. PubMed ID: 23201772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.